Evidence 1
Activity
Activity
32% Hemolysis
Toxicity
128 µM
Hemolytic
Cytotoxic
32% Hemolysis | 128 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Cu2+ reduces hemolytic activity of the antimicrobial peptide HMPI and enhances its trypsin resistance. | Acta Biochim Biophys Sin | 2020